A glioma is a type of tumor that originates in the central nervous system, specifically in the brain or spinal cord. These tumors originate in glial cells, supportive cells in the brain which serve to ...

For glioma patients, there are generally two main treatment paths: standard care, which includes surgery, radiation, and ...

As a companion diagnostic, Oncomine will be used to identify patients eligible for treatment with Servier’s Voranigo.

Thermo Fisher Scientific, the world leader in serving science, has received approval from the U.S. Food and Drug Administration (FDA) for its Ion Torrent™ Oncomine™ Dx Target Test as a companion ...

The FDA has approved the Ion Torrent Oncomine Dx Target Test as a companion diagnostic to identify patients eligible for ...

Announcement coincides with National Brain Cancer Awareness Day - October 24, and International Brain Tumour Awareness Week - ...

CLD-101 is a novel stem cell-based treatment that delivers oncolytic viruses to tumors, which may benefit patients with newly ...

The drug candidate – called vorasidenib – is a dual inhibitor of mutated IDH1 and IDH2, which is being developed for a hard-to-treat form of brain cancer called glioma. It was acquired by ...

Trial will evaluate multiple doses of CLD-101 for the treatment of newly diagnosed high-grade glioma CLD-101 is Calidi’s novel allogeneic immunotherapy utilizing neural stem cells to deliver ...

Diffuse midline glioma (DMG) is a highly aggressive and fatal pediatric high-grade glioma that primarily affects critical regions of the central nervous system, such as the pons, thalamus ...